Effects of dehydroepiandrostenedione, superimposed on growth hormone substitution, on quality of life and insulin-like growth factor I in patients with secondary adrenal insufficiency: a randomized, placebo-controlled, cross-over trial.
Analysis and Interpretation of Data: I. Factors possibly affecting sexual function in menopause. Some women are not bothered by this, but others are.
A recent study on a hyaluronic-based vaginal gel also identified a trend of improving of vaginal microbiota composition [ 78 ]. Meixel A. For women with GSM and no other menopausal symptoms, local estrogen therapy is recommended and has been the treatment of choice for decades.
In women going through the natural menopausal transition, a comprehensive, longitudinal study has found that prior function and relationship factors have a stronger impact on female sexual function than hormone concentrations A Androgen regulation of the mesocorticolimbic system and executive function.
Adrenal insufficiency is associated with impaired quality of life, low libido and lack of wellbeing Arlt and Allolio, a ; Lovas et al.
Bondi C. From to , the diagnosis of hypoactive sexual desire disorder HSDD depended on the symptom of absent or reduced desire for sexual activity and lack of sexual fantasies, with associated clinically significant distress. In this study, the most common adverse events were insomnia 7.
Advanced Search. Bremelanotide for female sexual dysfunctions in premenopausal women: A randomized, placebo-controlled dose-finding trial. No difference emerged in terms of adverse effects among different estrogenic preparations and between local estrogens vs.